Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Return on Equity (2016 - 2023)

Historic Return on Equity for Gsk (GLAXF) over the last 11 years, with Q4 2023 value amounting to 0.83%.

  • Gsk's Return on Equity changed N/A to 0.83% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.83%, marking a year-over-year change of. This contributed to the annual value of 0.78% for FY2022, which is 6700.0% up from last year.
  • Per Gsk's latest filing, its Return on Equity stood at 0.83% for Q4 2023.
  • Gsk's 5-year Return on Equity high stood at 4.11% for Q3 2019, and its period low was 0.79% during Q1 2021.
  • Moreover, its 3-year median value for Return on Equity was 2.15% (2019), whereas its average is 2.1%.
  • Data for Gsk's Return on Equity shows a peak YoY increase of 14000bps (in 2019) and a maximum YoY decrease of -16200bps (in 2019) over the last 5 years.
  • Gsk's Return on Equity (Quarter) stood at 1.95% in 2019, then tumbled by -59bps to 0.79% in 2021, then rose by 5bps to 0.83% in 2023.
  • Its Return on Equity stands at 0.83% for Q4 2023, versus 0.79% for Q1 2021 and 1.95% for Q4 2019.